This federal contract award, valued at $34,643.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Artesunate 110 mg vials, a critical medical commodity. This is a firm fixed-price delivery order contract with an ultimate completion date of April 1, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite...
This federal contract award, valued at $32,464.96, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order classified as Firm Fixed Price, with an ultimate completion date of November 22, 2024. The award is for the supply of Artesunate for Injection, a critical pharmaceutical product. This contract is a part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Artesunate for Injection. The contract has a ceiling value of $30,456.12 and is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of the pharmaceutical product Artesunate for injection. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The contract has a ceiling value of $32,464.96 and runs through November 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation....
This federal contract award, valued at $19,816.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,730,519 units of Artesunate 110 mg vials, a critical medical commodity. The contract has a completion date of November 7, 2023 and is structured as a firm fixed-price delivery order. The award was made through full and open competition without any set-aside designations. Amerisourcebergen Drug...
This federal contract award, valued at $15,170.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,861,291 units of Artesunate 110 mg vials, a medication used to treat malaria. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 10, 2025. The contract is not designated as a set-aside....
This federal contract award, valued at $69,287.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $26,561.00 firm fixed price delivery order is for the supply of 110 mg artesunate vials. This delivery order is placed under an indefinite delivery contract (IDC) with Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,653.72 firm fixed-price delivery order is for the provision of medical supplies, specifically ARTESUNAT 110MG 2S, to support military healthcare programs. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $32,464.96, is for the delivery of ARTESUNATE FOR INJECT medical supplies. It is a Delivery Order contract with a Firm Fixed Price pricing type. The contract has an ultimate completion date of November 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery...